Description
Praziquantel is an anti-parasitic/anti-helminthic that is commonly used to treat schistosomiasis. Praziquantel increases membrane permeability, altering intracellular Ca2+ levels and inducing neuromuscular paralysis in parasites. Praziquantel may inhibit adenosine uptake and voltage-gated Ca2+ channels. In animal models, praziquantel reverses Schistosoma-induced hypertension and vascular remodeling.
References
Cioli D, Pica-Mattoccia L, Basso A, et al. Schistosomiasis control: praziquantel forever? Mol Biochem Parasitol. 2014 Jun 21;195(1):23-29. PMID: 24955523.
Chan JD, Zarowiecki M, Marchant JS. Ca2+ channels and praziquantel: a view from the free world. Parasitol Int. 2013 Dec;62(6):619-28. PMID: 23246536.
Crosby A, Jones FM, Kolosionek E, et al. Praziquantel reverses pulmonary hypertension and vascular remodeling in murine schistosomiasis. Am J Respir Crit Care Med. 2011 Aug 15;184(4):467-73. PMID: 21659614.